Chronic Myelomonocytic Leukemia

general

A myelodysplastic/myeloproliferative neoplasm which is characterized by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL fusion gene, fewer than 20 percent blasts in the bone marrow and blood, myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement.

78

Centers

231

Active Trials

$17M

Cancer Funding

Specific Cancer Types(1)

NameCenters
Chronic Myelomonocytic Leukemia-143

Top Centers for Chronic Myelomonocytic Leukemia(78)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
86.0
2
NCI Comprehensive
High-Volume Research Center
85.4
3
NCI Comprehensive
High-Volume Research Center
82.1
4
NCI Comprehensive
High-Volume Research Center
82.1
5
NCI Comprehensive
High-Volume Research Center
80.3
6
NCI Comprehensive
High-Volume Research Center
75.8
7
NCI Comprehensive
High-Volume Research Center
73.1
870.0
9
High-Volume Research Center
70.0
10
NCI Comprehensive
Active Research Program
68.7
11
Active Research Program
68.6
12
NCI Clinical
Active Research Program
67.7
13
NCI Comprehensive
Active Research Program
66.6
14
Active Research Program
66.6
15
NCI Comprehensive
Active Research Program
62.5
16
NCI Comprehensive
Active Research Program
62.5
17
NCI Comprehensive
Active Research Program
62.5
18
NCI Comprehensive
Active Research Program
62.5
19
Active Research Program
62.5
20
Active Research Program
62.5
21
Active Research Program
62.5
22
Active Research Program
62.5
23
Active Research Program
62.5
24
NCI Comprehensive
Active Research Program
56.8
25
NCI Comprehensive
Active Research Program
56.8
26
NCI Comprehensive
Active Research Program
56.8
27
NCI Comprehensive
Active Research Program
56.8
28
NCI Comprehensive
Active Research Program
56.8
29
NCI Comprehensive
Active Research Program
56.8
30
NCI Comprehensive
Active Research Program
56.8
31
Active Research Program
56.8
32
NCI Comprehensive
Active Research Program
55.9
33
NCI Comprehensive
Active Research Program
50.1
34
NCI Comprehensive
Active Research Program
50.1
35
NCI Comprehensive
Active Research Program
50.1
36
NCI Comprehensive
Active Research Program
50.1
37
Active Research Program
50.1
38
NCI Clinical
Active Research Program
50.1
39
NCI Comprehensive
Active Research Program
50.1
40
NCI Comprehensive
Active Research Program
50.1
41
Active Research Program
50.1
42
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
50.1
43
Active Research Program
50.1
44
Active Research Program
50.1
45
Active Research Program
50.1
46
NCI Comprehensive
Active Research Program
38.6
47
NCI Comprehensive
Active Research Program
38.6
48
NCI Comprehensive
Active Research Program
38.6
49
NCI Comprehensive
Active Research Program
38.6
50
NCI Clinical
Active Research Program
38.6
51
NCI Comprehensive
Active Research Program
38.6
52
NCI Comprehensive
Active Research Program
38.6
53
NCI Clinical
Active Research Program
38.6
54
NCI Comprehensive
Active Research Program
38.6
55
NCI Comprehensive
Active Research Program
38.6
56
NCI Comprehensive
Active Research Program
38.6
57
NCI Comprehensive
Active Research Program
38.6
58
NCI Clinical
Active Research Program
38.6
59
NCI Comprehensive
Active Research Program
38.6
60
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
38.6
61
NCI Clinical
Active Research Program
38.6
62
NCI Comprehensive
Active Research Program
38.6
6338.6
64
NCI Basic_laboratory
Active Research Program
38.6
65
Active Research Program
38.6
66
Active Research Program
38.6
67
BC CancerVancouver, BC
Active Research Program
38.6
68
Active Research Program
38.6
69
Active Research Program
38.6
70
NCI Comprehensive
28.5
71
NCI Comprehensive
28.5
72
NCI Comprehensive
28.5
73
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
28.5
74
NCI Comprehensive
28.5
7528.5
7628.5
7728.5
7828.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →